title: VIII. Treatment of chronic lymphocytic leukaemia, where are we heading?
authors.affiliation: University of California Irvine Medical Center, Orange, CA, USA.
authors.forename: Susan M
authors.initials: SM
authors.lastname: O'Brien
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000378:metabolism / Q000628:therapy*; D008297:Male; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D011947:Receptors, Antigen, B-Cell / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D009363:Neoplasm Proteins; D011947:Receptors, Antigen, B-Cell
keywords: CLL; therapy B-cell receptor inhibitor